SCHEMBL29831664

SCHEMBL29831664

O=C(O)CNC(=O)CN1C(=O)c2ccccc2C1=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.66
▸ CA9 Q16790 1/20 0.66
▸ KMT2A Q03164 5/20 0.64
▸ MEN1 O00255 3/20 0.64
▸ LMNA P02545 1/20 0.62
▸ PKM P14618 1/20 0.62
▸ KDM4E B2RXH2 2/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ MAPT P10636 2/20 0.61
▸ RAB9A P51151 1/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ USP2 O75604 1/20 0.55
▸ POLB P06746 2/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ CYP1A2 P05177 1/20 0.53
▸ AKR1B1 P15121 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ ALOX15 P16050 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16057586 1.00 CA12 (0.66) CA12CA9KMT2AMEN1LMNA
SCHEMBL19886995 0.88 KDM4E (0.72) KMT2AMEN1LMNAKDM4EALDH1A1
SCHEMBL11571278 0.85 KDM4E (0.59) CA12CA9KMT2AMEN1LMNA
SCHEMBL19891197 0.85 KDM4E (0.68) KMT2AMEN1LMNAKDM4EALDH1A1
SCHEMBL1414102 0.82 SMN1; SMN2 (0.78) CA12CA9KMT2AMEN1LMNA
SCHEMBL12896373 0.81 MAPT (0.63) CA12CA9KMT2AMEN1LMNA
SCHEMBL29923275 0.81 MAPT (0.63) CA12CA9KMT2AMEN1LMNA
SCHEMBL9935900 0.81 ALDH1A1 (0.75) CA12CA9KMT2AMEN1LMNA
SCHEMBL29389712 0.80 KDM4E (0.71) CA12CA9KMT2AMEN1LMNA
SCHEMBL22388821 0.80 KDM4E (0.71) CA12CA9KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109369635-B Compound or pharmaceutically acceptable salt thereof, application thereof and pharmaceutical composition 赛克里翁治疗有限公司 2023-06-30 — — CN disclosed
CN-109384778-B Use of a compound or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of a disease, health condition or disorder 赛克里翁治疗有限公司 2022-12-13 — — CN disclosed
CN-110016020-B Compound or pharmaceutically acceptable salt thereof, application and pharmaceutical composition thereof 赛克里翁治疗有限公司 2022-07-26 — — CN disclosed
Send feedback